Net Peptide Content vs True Retatrutide Price Per Mg

A retatrutide listing prices a vial by its label weight, not by the peptide inside it. If a 10 mg vial holds 90% peptide by mass, the $100 listing (catalog prices as of September 2026) buys 9.0 mg of peptide, so the true price-per-mg is $100 ÷ 9.0 = $11.11 rather than the $10.00 the label implies. Net peptide content is the fraction of the fill weight left after counterion salt, bound water, and residual solvent are subtracted. Divide the price by net milligrams, not label milligrams.

How do you convert a listed price into cost per mg of actual peptide?

The formula has two inputs and one division:

true price per mg = vial price ÷ (label mg × net peptide content)

Net content is whatever the certificate of analysis states for that lot. The table runs the division at five stated values against both catalog vial formats so you can read off the row nearest your own COA figure.

Net content (%)	10 mg vial: net mg	10 mg vial: $/mg	20 mg vial: net mg	20 mg vial: $/mg
100	10.0	10.00	20.0	9.75
95	9.5	10.53	19.0	10.26
90	9.0	11.11	18.0	10.83
85	8.5	11.76	17.0	11.47
80	8.0	12.50	16.0	12.19

Price per mg of peptide at five stated net-content values, computed as vial price ÷ (label mg × net content). Vial prices are the 10 mg ($100) and 20 mg ($195) catalog listings as of September 2026; the net-content values are reader inputs, not measured figures for any lot.

Twenty percentage points of net content move the 10 mg format from $10.00/mg to $12.50/mg, a 25% swing on the same sticker price. That is an order of magnitude larger than the 2.5% gap between the two formats at face value, which is the whole reason the plain price-per-mg division can rank two listings in the wrong order.

Does the 20 mg vial still beat the 10 mg on price per mg?

Only while its net content stays within a fixed ratio of the smaller vial’s. Setting the two per-mg expressions equal gives $195 ÷ (20 × b) = $100 ÷ (10 × a), which reduces to 195a = 200b, so b = 0.975a. The 20 mg format holds its advantage while its net content is at least 97.5% of the 10 mg vial’s — a relative margin, not a fixed number of points.

Against a 10 mg lot assaying 92% net, the 20 mg lot has to reach 0.975 × 92 = 89.7% to break even. Below that it is the more expensive milligram despite the lower headline price. Worked at the table’s own rows: a 10 mg vial at 95% net costs $10.53/mg, while a 20 mg vial at 85% net costs $11.47/mg, so the small format wins by $0.94/mg.

The practical consequence is that a two-format comparison needs two COAs, not one price list. Where the lots come from the same batch and share a net figure, the 20 mg vial is cheaper per mg and the comparison collapses back to the arithmetic in the budgeting math for a multi-week retatrutide protocol.

Which COA line sets the net number?

Peptide content, sometimes printed as “net peptide content” or “peptide assay,” measured by nitrogen determination, quantitative UV, or amino-acid analysis. That line, and only that line, feeds the denominator above.

HPLC purity does not. Purity is an area percentage among the peptide-related species in the injected sample, so a lot can read high on purity and still be a third salt and water by weight. The two fields answer different questions: purity asks what else is peptide in there, content asks how much of the powder is peptide at all.

Three supporting lines change the content figure when they are present: counterion identity (acetate and trifluoroacetate carry different mass per mole of peptide), water content by Karl Fischer, and residual solvent. A listing that publishes purity and mass confirmation but no content assay has left the denominator blank. These are research-use-only listings, and the content assay is the one line that states how much peptide the price is buying.

How does net content change the reconstitution math?

It changes the concentration the vial actually delivers, not the volume you add. A 10 mg label reconstituted with 2 mL of bacteriostatic water gives a nominal 10 ÷ 2 = 5 mg/mL. At 90% net content the vial holds 9.0 mg, so the real concentration is 9.0 ÷ 2 = 4.5 mg/mL.

On a U-100 syringe, 1 mL = 100 units, so 10 units is 0.1 mL. At the nominal 5 mg/mL that draw is 0.50 mg; at the real 4.5 mg/mL it is 0.45 mg, or 450 mcg. Reaching 0.50 mg takes 0.5 ÷ 4.5 = 0.111 mL, which is 11.1 units. A reconstitution calculator will run the same division, but it takes the label figure unless you feed it the net milligrams. How the chosen volume interacts with the price is separate arithmetic, covered in how reconstitution volume shifts the per-mg figure.

Why does a content shortfall cost more than its percentage?

Because vials are indivisible, so the shortfall gets rounded up to the next whole vial. Costing out 40 mg of peptide in 20 mg vials: at 100% net, two vials deliver exactly 40 mg for 2 × $195 = $390. At 90% net, two vials deliver 2 × 18 = 36 mg, 4 mg short, and the third vial takes the bill to 3 × $195 = $585. A 10-point content gap raises the cost of hitting that quantity by $195, or 50%, while the per-mg figure moves only from $9.75 to $10.83.

Tens of milligrams is the scale where this bites. The published phase 2 obesity trial randomised 338 adults to once-weekly subcutaneous retatrutide in 1 mg, 4 mg, 8 mg, and 12 mg arms over 48 weeks, with percentage change in body weight at 24 weeks as the primary endpoint and a least-squares mean of −17.5% in the 12 mg group against −1.6% for placebo, per the 2023 NEJM phase 2 report. At the 4 mg weekly figure from that dose range, ten weeks of material is 4 × 10 = 40 mg, the exact quantity above.

Weekly subcutaneous dosing carries into the registrational program: four phase 3 TRIUMPH studies assess once-weekly retatrutide against placebo in over 5800 participants, with percent change in body weight as the weight-management primary endpoint, per the TRIUMPH trial design paper. Multi-week totals, not single vials, are therefore the unit that the rounding penalty applies to, and the penalty stacks on top of any minimum order quantity the seller sets.

Ask for the peptide-content line by name before ordering. A seller quoting only an HPLC purity percentage has not stated the net number, and a third vial belongs in the budget until they do.